about
JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytesInhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytesDual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosisPathophysiology of Heart Failure.Toll-like receptor 4 deficiency: smaller infarcts, but no gain in function.Level of inflammatory factors in chronic hemodialysis patients with and without cardiovascular disease.A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.Emerging therapeutic targets in chronic heart failure: part II.Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circleAssociation between Inflammation and Cardiac Geometry in Chronic Kidney Disease: Findings from the CRIC Study.Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure.Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients.The varying faces of IL-6: From cardiac protection to cardiac failure.Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.The immune system and cardiac repair.Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury.Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.The rs2228145 polymorphism in the interleukin-6 receptor and its association with long-term prognosis after myocardial infarction in a pilot study.Overview of emerging pharmacotherapy in chronic heart failure.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Post-myocardial infarct inflammation and the potential role of cell therapy.Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism.Lung function, inflammation and cardiovascular mortality in Africans.From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities.Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.Protective Function of STAT3 in CVB3-Induced Myocarditis.Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease.Intermittent levosimendan treatment in patients with severe congestive heart failure.A novel peroxide-induced calcium transient regulates interleukin-6 expression in cardiac-derived fibroblasts.Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes.Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.Cardiac gene expression profile in rats with terminal heart failure and cachexia.Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells.Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts.Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control.Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging.
P2860
Q28567596-FCDEE1CB-CFD8-49F4-9FA3-F412954B007DQ28574979-83EF07C2-84CC-4CA2-BB08-11F3E846F722Q28580617-D6DA0E1B-5C36-4E09-AF9A-28223479E46CQ30315815-C8B22A42-1C3F-4332-B8B1-8861B6A32849Q33288891-DEA57BEA-ACDA-4716-AA76-E86621ED42B2Q33660722-DF6BABFA-FEBE-48A5-93CF-7E1E7B6D0251Q34349864-400B8B2D-7F4E-4A09-9E4B-7D4E1CCFDFBBQ35056026-F913D58C-B186-4289-96AF-977FD7C2F176Q35223968-92069D58-0A61-4BFC-92D6-46EB43A340F3Q35536642-96A1FA9B-9B87-44D8-8DA2-5AF0AD032B21Q35579754-7C3DA175-7DB6-4F7C-B1CD-9C0BBB7482B7Q35669321-8C67619A-8BEB-4A6C-ADA1-8FCA0765B197Q35723859-B1C8A46C-05E9-425D-BE93-8F12AEA6ED37Q36026534-D70FCFBD-EBD0-4075-8DD7-D96EBCFF218DQ36299334-2E0BFCE3-9A37-40AC-AAF0-331F8A68B0B6Q36368339-72194E77-9B35-463F-B693-522636C3A113Q36994116-B836CB23-30D4-436C-A73B-77081D871F87Q37096652-C3A90F44-9166-4103-94E6-E04F11B15F1AQ37235292-9BA4CA9F-64BD-4720-9F56-3091BFB0646DQ37469175-D857F037-A762-4BDB-96D5-365B2C597AC5Q37549334-B6AE24C7-7BB6-4937-9B36-5E7D9170BA7EQ37552943-5EDCCE4A-9341-4DC5-AAC2-B8D1D6D88C31Q38183314-F8D9C48F-AA40-4F2F-B497-DA65C720BD47Q38316469-F1551B4D-D0A1-402C-85C5-34A823B854C8Q38345676-C252231A-6203-447C-9A27-E30E543D6F02Q39417768-1D989177-5648-40B7-9C7F-5C1AA2742E58Q39434474-72BE4416-F430-4E13-8921-C4695F3C58B0Q41824383-827A1013-D341-4792-BAAF-B6B716B6F325Q41892375-D5164C14-0BA1-4146-A22E-EDE93266C3A0Q42687701-FDC37807-76C1-4819-84EC-93B0BBFCCD4DQ43961914-70ABBAC0-8812-47DB-B361-56A1E7EF81A8Q43976213-1602923B-19D3-4EC3-9366-45739C9CECB4Q44431309-892FE1DF-028D-4C9E-85E5-055A1B203D5AQ44693657-A100DAFD-8DC8-411A-8792-29CDFACBAC01Q45205031-0C7441A3-FF21-4D61-8541-6344F9DEFB29Q47108276-E5CDD06F-5DC1-4D04-A82A-8C65E30D29AAQ47808587-558CC414-2303-4CA3-BBEE-C274467C8094Q48015051-E7EC5507-2B62-449C-BA52-ECD63BFF849BQ48614840-C5DC9610-53F4-45A6-83EC-C630BB3A0407Q48646872-E1E3BA9E-00EC-4563-8AE2-C559EBA966CC
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of interleukin-6 in the failing heart.
@ast
The role of interleukin-6 in the failing heart.
@en
The role of interleukin-6 in the failing heart.
@nl
type
label
The role of interleukin-6 in the failing heart.
@ast
The role of interleukin-6 in the failing heart.
@en
The role of interleukin-6 in the failing heart.
@nl
prefLabel
The role of interleukin-6 in the failing heart.
@ast
The role of interleukin-6 in the failing heart.
@en
The role of interleukin-6 in the failing heart.
@nl
P356
P1476
The role of interleukin-6 in the failing heart.
@en
P2093
P2888
P304
P356
10.1023/A:1011401825680
P577
2001-03-01T00:00:00Z
P6179
1016429153